LORAZEPAM

1. PURPOSE

To authorize CCP’s to monitor, adjust, and administer intravenous Lorazepam

2. POLICY

2.1. CCP’s are permitted to monitor and adjust Lorazepam established infusions
2.2. CCP’s are permitted to administer Lorazepam IV push doses
2.3. CCP’s may not initiate Lorazepam infusions

3. PROCEDURE

3.1. The infusion concentration and regulations of the infusion rate will occur within the parameters as
defined by the transferring physician, but may be titrated to the individual’s response, during
transport.

3.2. In cases of an adverse event, the medication infusion will be discontinued, and the transferring

physician and/or base hospital are to be notified.

3.3. Typical Lorazepam infusion concentration is 100 mg/100 ml at a rate of 2-4 mg/hr.
3.4. In case of severe alcohol withdraws, significantly higher doses may be required.

4. ADMINISTRATION

4.1. CCP’s shall be permitted to administer Lorazepam as a second line medication in situations

where Midazolam is contraindicated, has been ineffective, or is preferred over Midazolam by the
transferring, receiving, or base hospital physician.

4.2. Standard Dose:

4.2.1.  1 mg IV/IM q 5 mins to a max of 5 mg prn. IN preferred dose volume 0.25-0.5 ml

per nare not to exceed 1 ml of volume per nare per dose.

4.2.2.  If concern for hypotension or respiratory depression you may administer ½ dose (0.5mg).

4.3. Weight-Based Dose – Pediatrics less than 25 kg:

4.3.1.  Administer 0.1 mg/kg IV/IM/IN as q 5 mins prn.
4.3.2.  Maximum single dose is 2 mg.
4.3.3.  Larger doses may be needed than typical adult dosing.
4.3.4.  Must be diluted with NS for IV administration to a strength of 1 mg/ml for all patients

weighing less than 25 kg.

19

